El-Malah, A.A.; Gineinah, M.M.; Deb, P.K.; Khayyat, A.N.; Bansal, M.; Venugopala, K.N.; Aljahdali, A.S.
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals 2022, 15, 827.
https://doi.org/10.3390/ph15070827
AMA Style
El-Malah AA, Gineinah MM, Deb PK, Khayyat AN, Bansal M, Venugopala KN, Aljahdali AS.
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals. 2022; 15(7):827.
https://doi.org/10.3390/ph15070827
Chicago/Turabian Style
El-Malah, Afaf A., Magdy M. Gineinah, Pran Kishore Deb, Ahdab N. Khayyat, Monika Bansal, Katharigatta N. Venugopala, and Anfal S. Aljahdali.
2022. "Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing" Pharmaceuticals 15, no. 7: 827.
https://doi.org/10.3390/ph15070827
APA Style
El-Malah, A. A., Gineinah, M. M., Deb, P. K., Khayyat, A. N., Bansal, M., Venugopala, K. N., & Aljahdali, A. S.
(2022). Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals, 15(7), 827.
https://doi.org/10.3390/ph15070827